查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1756406

CRISPR 和 Cas 基因市场，按产品类型、按技术、按交付方式、按治疗领域、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

CRISPR And Cas Genes Market, By Product Type, By Technology, By Delivery Method, By Therapeutic Area, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年 CRISPR 和 Cas 基因市场规模价值 47.0129 亿美元，2025 年至 2032 年的复合年增长率为 16.50%。

CRISPR 和 Cas 基因市场-市场动态

精准基因编辑技术的进步加速市场成长

精准基因编辑技术的进步，尤其是 CRISPR 和 Cas 基因的进步，正在显着加速全球研究和治疗应用。根据美国国立卫生研究院 (NIH) 的数据，目前超过 70% 的基因编辑临床试验都集中在 CRISPR-Cas 系统上，因为它们精准且有效率。美国食品药物管理局 (FDA) 最近批准了几种利用这些工具的基因疗法，反映出监管机构的认可度不断提高。此外，人类基因组计画等全球性计画不断拓展人们对遗传疾病的理解，推动了对精准基因编辑解决方案的需求。然而，脱靶效应和伦理考量等挑战依然存在，这为改善安全性和给药方案的创新创造了机会。这些进步正在建立一个充满活力的格局，精准基因编辑在解决复杂遗传疾病和推进个人化医疗方面发挥关键作用。

CRISPR 和 Cas 基因市场—关键洞察

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 16.50%。

根据产品类型细分，预计该产品将在 2024 年占据最大市场份额

根据技术细分，CRISPR/Cas9 是 2024 年的领先技术

根据递送方式细分，病毒载体是 2024 年最主要的递送方式

根据治疗领域细分，肿瘤学是 2024 年领先的治疗领域

根据最终用户细分，生物技术和製药公司是 2024 年领先的最终用户

按地区划分，北美是 2024 年的主要收入来源

CRISPR 和 Cas 基因市场-細項分析：

全球 CRISPR 和 Cas 基因市场根据产品类型、技术、交付方式、治疗领域、最终用户和地区进行细分。

根据产品类型，市场分为两类：产品（试剂盒、试剂和文库）和服务（微生物基因编辑、细胞株工程、gRNA 设计与合成、DNA 合成、筛选服务及其他）。产品类别以试剂盒和试剂（包括 Cas 蛋白和嚮导 RNA）为主，其次是以设计工具和抗体为特色的文库。服务专注于微生物基因编辑、细胞株工程、gRNA 设计、DNA 合成和筛选，支援全球全面的基因编辑工作流程。

根据技术，市场分为三类：CRISPR/Cas9、CRISPR/Cas12、CRISPR/Cas13 和其他。 CRISPR/Cas9 在精准基因编辑应用领域占据主导地位，其次是用于诊断和治疗的 CRISPR/Cas12。 CRISPR/Cas13 专注于 RNA 靶向，而其他技术则包括新兴变体，正在拓展其在全球研究和临床领域的能力。

CRISPR 和 Cas 基因市场—地理洞察

在强大的科学研究基础设施和政府支持的推动下，CRISPR 和 Cas 基因市场在北美、欧洲和亚太地区表现强劲。北美市场领先，得益于美国国立卫生研究院等机构的大量资金投入，以及波士顿和旧金山等领先生物技术中心的设立。欧洲紧随其后，德国、英国和法国等国家透过欧盟「地平线」计画支持的措施推进基因编辑研究。亚太地区发展迅速，尤其是在中国、日本和韩国，这些国家不断增加的生物技术投资和配套的监管框架正在促进创新和商业化。拉丁美洲和中东的新兴市场也开始将基因编辑技术应用于医疗保健和农业，儘管速度较慢。全球性的合作和学术伙伴关係正在进一步加强 CRISPR 和 Cas 基因的全球影响力，凸显了区域专业知识和资源可用性在推动市场发展中的重要性。

CRISPR 和 Cas 基因市场—竞争格局：

CRISPR 和 Cas 基因市场的竞争格局由主要生物技术公司、学术机构和专注于推进基因编辑技术的创新新创公司塑造。 Editas Medicine、CRISPR Therapeutics 和 Intellia Therapeutics 等主要参与者正在积极开发专有的 CRISPR-Cas 平台，并透过策略合作和授权协议拓展其技术能力。学术研究中心透过发现新的 Cas 变体和改进递送方法做出了重要贡献，从而推动了创新。新创公司也涌现出包括碱基编辑和主要编辑在内的利基技术，以提高精确度并减少脱靶效应。智慧财产权发挥着至关重要的作用，持续的专利纠纷影响着竞争态势。与製药公司和研究机构的合作加速了治疗药物的开发和商业化。此外，随着企业努力满足全球治疗和农业应用领域日益增长的需求，对可扩展生产和改进的生物资讯工具的研发投入正在加剧竞争。

最新动态：

2024年11月，Vertex与CRISPR Therapeutics获得全球首个基于CRISPR/Cas9的基因编辑疗法CASGEVY的授权，用于治疗镰状细胞病和输血依赖性β地中海贫血，标誌着CRISPR和Cas基因技术临床应用的重要里程碑。

2024年8月，CRISPR QC在其CRISPR分析平台中推出了三款创新产品－RNP形成、DNA标靶结合和CLEAVE，为CRISPR/Cas基因编辑工作流程提供即时洞察。这些工具优化了基因编辑研究和治疗开发的效率、准确性和品质控制。

2025年1月，奥胡斯大学的研究人员发表了一项三重作用的CRISPR技术，能够同时在人类原代T细胞中实现基因活化、抑制和删除。这项突破性进展利用了多个CRISPR/Cas系统，推动了复杂的基因工程在细胞治疗和再生医学领域的应用。

目录

第一章：CRISPR 和 Cas 基因市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • CRISPR 和 Cas 基因市场片段（依产品类型）
    • CRISPR 和 Cas 基因市场技术片段
    • CRISPR 和 Cas 基因市场片段（以交付方式）
    • CRISPR 和 Cas 基因市场片段（按治疗领域）
    • CRISPR 和 Cas 基因市场片段（按最终用户）
    • CRISPR 和 Cas 基因市场（按国家/地区）
    • CRISPR 和 Cas 基因市场（按地区）
  • 竞争洞察

第三章：CRISPR 和 Cas 基因关键市场趋势

  • CRISPR 和 Cas 基因市场驱动因素
    • 市场驱动因素的影响分析
  • CRISPR 和 Cas 基因市场限制
    • 市场限制的影响分析
  • CRISPR 和 Cas 基因的市场机会
  • CRISPR 和 Cas 基因市场未来趋势

第四章：CRISPR 和 Cas 基因产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：CRISPR 与 Cas 基因市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：CRISPR 和 Cas 基因市场模式

  • 2024年CRISPR和Cas基因市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：CRISPR 和 Cas 基因市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 产品
      • 试剂盒和试剂
      • Cas 蛋白和酶
      • 嚮导RNA
      • 其他的
      • 图书馆
      • 设计工具
      • 抗体
      • 其他的
    • 服务
      • 微生物基因编辑
      • 细胞株工程
      • gRNA设计与合成
      • DNA合成
      • 筛检服务
      • 其他的

第 8 章：CRISPR 和 Cas 基因市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • CRISPR/Cas9
    • CRISPR/Cas12
    • CRISPR/Cas13
    • 其他的

第九章：CRISPR 和 Cas 基因市场 - 按交付方式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 物理方法（电穿孔、显微注射）
    • 病毒载体
    • 非病毒载体

第十章：CRISPR 和 Cas 基因市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 肿瘤学
    • 遗传性疾病
    • 传染病
    • 其他的

第 11 章：CRISPR 和 Cas 基因市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 生技与製药公司
    • 学术和政府研究机构
    • 合约研究组织（CRO）

第 12 章：CRISPR 和 Cas 基因市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美 CRISPR 和 Cas 基因主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（以交付方式）
    • 北美市场规模及预测（按治疗领域）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲CRISPR和Cas基因主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（以交付方式）
    • 欧洲市场规模及预测（按治疗领域）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区 CRISPR 和 Cas 基因主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（以交付方式）
    • 亚太地区市场规模及预测（依治疗领域）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲的 CRISPR 和 Cas 基因主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（以交付方式）
    • 拉丁美洲市场规模及预测（按治疗领域）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的 CRISPR 和 Cas 基因主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（以交付方式）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：关键供应商分析 - CRISPR 和 Cas 基因产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Addgene
    • Beam Therapeutics
    • Caribou Biosciences
    • CRISPR Therapeutics AG
    • Editas Medicine
    • GenScript Biotech Corporation
    • Horizon Discovery Group
    • Integrated DNA Technologies (IDT)
    • Intellia Therapeutics
    • Mammoth Biosciences
    • Merck KGaA (Sigma-Aldrich)
    • New England Biolabs
    • Precision BioSciences
    • Synthego Corporation
    • Thermo Fisher Scientific
    • ToolGen Inc.
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5305

REPORT HIGHLIGHT

CRISPR And Cas Genes Market size was valued at US$ 4,701.29 Million in 2024, expanding at a CAGR of 16.50% from 2025 to 2032.

The CRISPR and Cas Genes Market involves advanced gene-editing technologies used for precise genetic modifications across research, therapeutic, and agricultural applications. Increasing adoption of gene-editing tools for developing personalized medicine and disease-resistant crops boosts innovation, while challenges like ethical concerns and regulatory hurdles limit rapid growth. Growing investments in genetic research have led to a surge in CRISPR patent filings, with over 3,000 patents recorded by major institutions globally. Opportunities lie in expanding applications in rare genetic disorders and regenerative medicine, supported by initiatives from organizations like the National Institutes of Health (NIH), promoting genome editing research. However, complexities in delivery methods and off-target effects pose restraints, underscoring the need for improved accuracy and safety in gene-editing practices.

CRISPR And Cas Genes Market- Market Dynamics

Advancements in Precision Gene Editing to Accelerate Market Growth

Advancements in precision gene editing technologies, particularly involving CRISPR and Cas genes, are significantly accelerating research and therapeutic applications worldwide. According to the National Institutes of Health (NIH), over 70% of gene-editing clinical trials currently focus on CRISPR-Cas systems due to their accuracy and efficiency. The U.S. Food and Drug Administration (FDA) has recently approved several gene therapies utilizing these tools, reflecting growing regulatory acceptance. Furthermore, global initiatives like the Human Genome Project continue to expand understanding of genetic diseases, fueling demand for precise gene-editing solutions. However, challenges such as off-target effects and ethical considerations persist, opening opportunities for innovations that improve safety and delivery. These advancements are fostering a dynamic landscape where precision gene editing plays a pivotal role in addressing complex genetic disorders and advancing personalized medicine.

CRISPR And Cas Genes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.50% over the forecast period (2025-2032)

Based on product type segmentation, the Product was predicted to show maximum market share in the year 2024

Based on Technology segmentation, CRISPR/Cas9 was the leading Technology in 2024

Based on Delivery Method segmentation, Viral Vectors were the leading Delivery Method in 2024

Based on Therapeutic Area segmentation, Oncology was the leading Therapeutic Area in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

CRISPR And Cas Genes Market- Segmentation Analysis:

The Global CRISPR and Cas Genes Market is segmented on the basis of Product Type, Technology, Delivery Method, Therapeutic Area, End User, and Region.

The market is divided into two categories based on product type: Product (Kits & Reagents and Libraries), and Service (Microbial Gene Editing, Cell Line Engineering, gRNA Design & Synthesis, DNA Synthesis, Screening Services, and Others). Product segment leads with Kits & Reagents, including Cas Proteins and Guide RNA, followed by Libraries featuring design tools and antibodies. Services focus on microbial gene editing, cell line engineering, gRNA design, DNA synthesis, and screening, supporting comprehensive gene-editing workflows globally.

The market is divided into three categories based on Technology: CRISPR/Cas9, CRISPR/Cas12, CRISPR/Cas13, and Others. CRISPR/Cas9 dominates with precise gene editing applications, followed by CRISPR/Cas12 used in diagnostics and therapeutics. CRISPR/Cas13 specializes in RNA targeting, while others include emerging variants expanding capabilities across research and clinical settings worldwide.

CRISPR And Cas Genes Market- Geographical Insights

The CRISPR and Cas Genes market shows strong activity across North America, Europe, and Asia-Pacific, driven by robust research infrastructure and government support. North America leads due to substantial funding from agencies like the National Institutes of Health and the presence of leading biotech hubs such as Boston and San Francisco. Europe follows closely, with countries like Germany, the UK, and France advancing gene-editing research through initiatives supported by the European Union's Horizon programs. Asia-Pacific is rapidly growing, especially in China, Japan, and South Korea, where increasing investments in biotechnology and supportive regulatory frameworks are fostering innovation and commercialization. Emerging markets in Latin America and the Middle East are beginning to adopt gene-editing technologies for healthcare and agricultural applications, although at a slower pace. Collaborative efforts and academic partnerships worldwide are further strengthening the global footprint of CRISPR and Cas genes, highlighting the importance of regional expertise and resource availability in advancing the market.

CRISPR And Cas Genes Market- Competitive Landscape:

The competitive landscape of the CRISPR and Cas Genes market is shaped by key biotechnology companies, academic institutions, and innovative startups focusing on advancing gene-editing technologies. Major players such as Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics are actively developing proprietary CRISPR-Cas platforms, with strategic collaborations and licensing agreements expanding their technological capabilities. Academic research centers contribute significantly by discovering new Cas variants and improving delivery methods, fueling innovation. Startups are also emerging with niche technologies, including base editing and prime editing, enhancing precision and reducing off-target effects. Intellectual property rights play a critical role, with ongoing patent disputes influencing competitive dynamics. Partnerships with pharmaceutical companies and research organizations accelerate therapeutic development and commercialization efforts. Additionally, investment in R&D for scalable production and improved bioinformatics tools is intensifying competition, as firms strive to meet growing demand across therapeutic and agricultural applications globally.

Recent Developments:

In November 2024, Vertex and CRISPR Therapeutics received authorization for the world's first CRISPR/Cas9-based gene editing therapy, CASGEVY, for sickle cell disease and transfusion-dependent beta thalassemia, marking a major milestone in the clinical application of CRISPR and Cas gene technologies.

In August 2024, CRISPR QC launched three innovative products-RNP Formation, DNA Target Binding, and CLEAVE-within its CRISPR Analytics Platform, offering real-time insights into CRISPR/Cas gene editing workflows. These tools optimize efficiency, accuracy, and quality control for gene editing research and therapeutic development.

In January 2025, Researchers at Aarhus University unveiled a triple-action CRISPR technology enabling simultaneous gene activation, repression, and deletion in primary human T cells. This breakthrough uses multiple CRISPR/Cas systems, advancing complex genetic engineering for cell therapy and regenerative medicine applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Addgene
  • Beam Therapeutics
  • Caribou Biosciences
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript Biotech Corporation
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Intellia Therapeutics
  • Mammoth Biosciences
  • Merck KGaA (Sigma-Aldrich)
  • New England Biolabs
  • Precision BioSciences
  • Synthego Corporation
  • Thermo Fisher Scientific
  • ToolGen Inc.
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Product
  • Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
  • Libraries
  • Design Tool
  • Antibodies
  • Others
  • Service
  • Microbial Gene Editing
  • Cell Line Engineering
  • gRNA Design & Synthesis
  • DNA Synthesis
  • Screening Services
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • CRISPR/Cas9
  • CRISPR/Cas12
  • CRISPR/Cas13
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Physical Methods (Electroporation, Microinjection)
  • Viral Vectors
  • Non-Viral Vectors

GLOBAL CRISPR AND CAS GENES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL CRISPR AND CAS GENES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR And Cas Genes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR And Cas Genes Market Snippet by Product Type
    • 2.1.2. CRISPR And Cas Genes Market Snippet by Technology
    • 2.1.3. CRISPR And Cas Genes Market Snippet by Delivery Method
    • 2.1.4. CRISPR And Cas Genes Market Snippet by Therapeutic Area
    • 2.1.5. CRISPR And Cas Genes Market Snippet by End User
    • 2.1.6. CRISPR And Cas Genes Market Snippet by Country
    • 2.1.7. CRISPR And Cas Genes Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR And Cas Genes Key Market Trends

  • 3.1. CRISPR And Cas Genes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR And Cas Genes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR And Cas Genes Market Opportunities
  • 3.4. CRISPR And Cas Genes Market Future Trends

4. CRISPR And Cas Genes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR And Cas Genes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR And Cas Genes Market Landscape

  • 6.1. CRISPR And Cas Genes Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR And Cas Genes Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Product
      • 7.1.2.1. Kits & Reagents
      • 7.1.2.1.1. Cas Proteins & Enzymes
      • 7.1.2.1.2. Guide RNA
      • 7.1.2.1.3. Others
      • 7.1.2.2. Libraries
      • 7.1.2.2.1. Design Tool
      • 7.1.2.2.2. Antibodies
      • 7.1.2.2.3. Others
    • 7.1.3. Service
      • 7.1.3.1. Microbial Gene Editing
      • 7.1.3.2. Cell Line Engineering
      • 7.1.3.3. gRNA Design & Synthesis
      • 7.1.3.4. DNA Synthesis
      • 7.1.3.5. Screening Services
      • 7.1.3.6. Others

8. CRISPR And Cas Genes Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. CRISPR/Cas9
    • 8.1.3. CRISPR/Cas12
    • 8.1.4. CRISPR/Cas13
    • 8.1.5. Others

9. CRISPR And Cas Genes Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 9.1.2. Physical Methods (Electroporation, Microinjection)
    • 9.1.3. Viral Vectors
    • 9.1.4. Non-Viral Vectors

10. CRISPR And Cas Genes Market - By Therapeutic Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 10.1.2. Oncology
    • 10.1.3. Genetic Disorders
    • 10.1.4. Infectious Diseases
    • 10.1.5. Others

11. CRISPR And Cas Genes Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Biotechnology & Pharmaceutical Companies
    • 11.1.3. Academic & Government Research Institutes
    • 11.1.4. Contract Research Organizations (CROs)

12. CRISPR And Cas Genes Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. CRISPR And Cas Genes Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. CRISPR And Cas Genes Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. CRISPR And Cas Genes Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. CRISPR And Cas Genes Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. CRISPR And Cas Genes Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- CRISPR And Cas Genes Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Addgene
    • 13.2.2. Beam Therapeutics
    • 13.2.3. Caribou Biosciences
    • 13.2.4. CRISPR Therapeutics AG
    • 13.2.5. Editas Medicine
    • 13.2.6. GenScript Biotech Corporation
    • 13.2.7. Horizon Discovery Group
    • 13.2.8. Integrated DNA Technologies (IDT)
    • 13.2.9. Intellia Therapeutics
    • 13.2.10. Mammoth Biosciences
    • 13.2.11. Merck KGaA (Sigma-Aldrich)
    • 13.2.12. New England Biolabs
    • 13.2.13. Precision BioSciences
    • 13.2.14. Synthego Corporation
    • 13.2.15. Thermo Fisher Scientific
    • 13.2.16. ToolGen Inc.
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us